
Breast HER2 AI
Developed by Indica Labs, the Breast HER2 AI solution leverages deep learning that standardizes scoring of HER2 in resections, excisions, or biopsies from primary invasive breast cancer samples. The algorithm reports quantitative results and markup images, including tumor detection, HER2 score, HER2 grade (including low and ultralow), and percentage positive cells.
Breast HER2 AI is For Research Use Only and not intended for clinical diagnostic use. Breast HER2 AI accessed via the Aperio HALO AP image management system.






Breast HER2 AI in Aperio HALO AP Demonstration
Explore the future of pathology with the Breast HER2 AI app from Indica Labs. Breast HER2 AI seamlessly integrates within the Aperio HALO AP enterprise digital pathology platform to identify and score HER2 tumor cells in primary invasive breast cancer samples.
After selecting an image, view the IHC slide in the viewer and the Breast HER2 AI results. Results include overlays and quantitative results. The first set of overlays prepare the tissue for analysis by identifying areas of analyzable tissue. The next overlay identifies areas of tumor in the tissue. The final overlay identifies and classifies cells for HER2 positivity within the tumor area. Finally, quantitative results at a per slide level are displayed in the assay panel to the right.